<DOC>
	<DOCNO>NCT02984072</DOCNO>
	<brief_summary>Topical photodynamic therapy ( PDT ) widely use treat superficial non-melanoma skin cancer ( NMSC ) dysplasia , notably actinic keratosis may also effective range dermatological condition . A major limitation PDT pain irradiation . A lack knowledge mechanism PDT-induced pain limit development effective approach prevention relief adverse effect . The investigator investigate possible efficacy menthol PDT pain ex vivo study clinical trial . This proposal describe prospective randomise double blind , placebo control clinical trial undertaken investigate use topical menthol PDT-induced pain relief patient actinic keratosis face scalp attend general dermatology PDT outpatient clinic Ninewells Hospital , Dundee .</brief_summary>
	<brief_title>Menthol PDT Pain</brief_title>
	<detailed_description>This proposal describe prospective randomise double blind , placebo control clinical trial undertaken investigate use topical menthol PDT-induced pain relief patient actinic keratosis face scalp attend general dermatology PDT outpatient clinic Ninewells Hospital , Dundee . This undertaken comparison 5 % menthol aqueous cream aqueous cream placebo primary outcome measure pain record visual analogue scale ( VAS ) 24 h PDT . Secondary outcomes phototoxicity , assess semi-quantitative scoring system immediately PDT , fluorescence assess routinely cream application irradiation outcome base clinical assessment three month PDT patient evaluation . Patients involve study first visit PDT three-month assessment visit PDT . Data analysis undertaken use within-subject paired analysis patient act control . Information study inform investigator whether topical menthol routinely incorporated PDT treatment regimens order reduce pain increase tolerance treatment . The information also provide additional information mechanism PDT-induced pain possible prevention and/or relief .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>A subject eligible inclusion study follow criterion apply : 1 . Adults &gt; 18 year . Target population men woman â‰¥50 year ( postmenopausal woman ) 2 . Presence actinic keratoses ( AK ) face scalp involve right left comparable site . 3 . Free significant physical abnormality ( e.g . tattoo , dermatosis ) potential treatment area may cause difficulty examination final evaluation . 4 . Able understand adhere protocol requirement . 1 . Unable give write informed consent . 2 . Allergy menthol , aqueous cream excipients 3 . Participation drug trial interventional study within 30 day recruitment study 4 . Premenopausal woman , pregnancy , breast feeding , plan conceive 5 . Chronic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>